It is noteworthy, though, that unlike GLI1, GLI2 is not a transcriptional target of the Hh pathway and its overexpression in SSc is putatively attributed to the known TGF-β/Smad-induced activation of the GLI2 promoter [27]. The gene discussed is GLI1; the disease is systemic sclerosis.